⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4409028 | 1.00 | — | — | |
| SCHEMBL13062506 | 1.00 | — | — | |
| SCHEMBL346604 | 1.00 | — | — | |
| SCHEMBL9564560 | 1.00 | — | — | |
| SCHEMBL4409027 | 1.00 | — | — | |
| SCHEMBL8927312 | 0.91 | THRB (0.43) | — | |
| SCHEMBL13669944 | 0.89 | THRB (0.50) | — | |
| SCHEMBL1491969 | 0.89 | THRB (0.50) | — | |
| SCHEMBL26509369 | 0.89 | THRB (0.50) | — | |
| E968 SCHEMBL5202199 | 0.87 | THRB (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250241869-A1 | COMPOSITIONS AND METHODS COMPRISING DEOXY-PENTITOLS | THE CHARLOTTE MECKLENBURG HOSPITAL AUTHORITY D/B/A ATRIUM HEALTH (US) | 2025-07-31 | — | — | US | claimed |
| US-12257214-B2 | Compositions and methods comprising deoxy-pentitols | THE CHARLOTTE MECKLENBURG HOSPITAL AUTHORITY (US) | 2025-03-25 | — | — | US | claimed |
| WO-2022256467-A1 | COMPOSITIONS AND METHODS COMPRISING DEOXY-PENTITOLS | THE CHARLOTTE MECKLENBURG HOSPITAL AUTHORITY D/B/A ATRIUM HEALTH (US) | 2022-12-08 | — | — | WO | claimed |
| US-20220387346-A1 | COMPOSITIONS AND METHODS COMPRISING DEOXY-PENTITOLS | THE CHARLOTTE MECKLENBURG HOSPITAL AUTHORITY D/B/A ATRIUM HEALTH | 2022-12-08 | — | — | US | claimed |
| CN-105792832-B | Organic compounds for the treatment of hepatitis B virus | 诺华股份有限公司 | 2021-03-23 | — | — | CN | claimed |
| US-8642644-B2 | Ophthamological drugs | DUKE UNIVERSITY (US) | 2014-02-04 | — | — | US | claimed |
| US-7858775-B2 | Production of 2′-deoxynucleosides and 2′-deoxynucleoside precursors from 2-dehydro-3-deoxy-D-gluconate | RHODIA CHIMIE (FR) | 2010-12-28 | — | — | US | claimed |
| US-20090318542-A1 | OPHTHAMOLOGICAL DRUGS | DUKE UNIVERSITY | 2009-12-24 | — | — | US | claimed |
| EP-1812017-A2 | OPHTHAMOLOGICAL DRUGS | Duke University (US) | 2007-08-01 | — | — | EP | claimed |
| EP-1627882-B1 | Process for the preparation of alkypolyglycosides | GOLDSCHMIDT GMBH (DE) | 2006-11-22 | — | — | EP | claimed |
| US-20060135609-A1 | Ophthamological drugs | DUKE UNIVERSITY (US) | 2006-06-22 | — | — | US | claimed |
| WO-2006047466-A2 | OPHTHAMOLOGICAL DRUGS | DUKE UNIVERSITY (US) | 2006-05-04 | — | — | WO | claimed |
| EP-1627882-A1 | Process for the preparation of alkypolyglycosides | Goldschmidt GmbH (DE) | 2006-02-22 | — | — | EP | claimed |
| US-5789572-A | DEHYDRATION CYCLIZATION OF 2-DEOXY-D-ERYTHROPENITOL | NIKKO RICA CO., LTD. (JP) | 1998-08-04 | — | — | US | claimed |
| EP-0450585-A2 | Process for the manufacture of 2-deoxy-D-threo-pentofuranosides, intermediates for their manufacture and their use | CHEMPROSA, CHEMISCHE PRODUKTE SAISCHEK GmbH (AT) | 1991-10-09 | — | — | EP | claimed |
| JP-59136488-A | — | — | None | — | — | JP | disclosed |
| JP-9316065-A | — | — | None | — | — | JP | disclosed |
| EP-0237829-B1 | HETEROCYCLIC TETRAHYDRO-3,4-DIAMINE-N-N'-PLATINUM COMPLEXES | AMERICAN CYANAMID COMPANY (US) | 1990-10-31 | — | — | EP | disclosed |
| US-4716157-A | ANTITUMOR AGENTS | AMERICAN CYANAMID COMPANY (US) | 1987-12-29 | — | — | US | disclosed |
| JP-S59136488-A | PREPARATION OF 2-DEOXY-D-ERYTHRO-PENTOSE | NOGUCHI KENKYUSHO | 1984-08-06 | — | — | JP | disclosed |